Document is current
Any future updates will be listed below
-
Authors
Barras, Nicolas
Kikoïne, John
Liaudet, Lucas
Sotiropoulos, Konstantinos
Regamey, Julien
Godinho, Rita
Hullin, Roger
Yerly, Patrick https://orcid.org/0000-0001-8163-722X
-
Funding
Funding for this research was provided by:
Orion Corporation
- License Information
-
More Information
Article History
Received: 8 December 2025
Accepted: 15 May 2026
First Online: 3 June 2026
Declarations
:
: The study was approved by our institutional ethics committee (CER-VD-244/14) and complied with the declaration of Helsinki.
: Informed consent was waived due to the retrospective nature of the study.
: The last author (PY) was the recipient of an unrestricted research grant from Orion Pharma, Espoo, Finland. He also reports consulting for MSD, Johnson & Johnson, Bayer, Novartis, and Servier. JK received speaker’s fees from AstraZeneca and Bristol Myers Squibb. The other authors declare that they have no competing interests.
